DiscoverCME in Minutes: Education in Primary CareYasha Modi, MD - Putting Evidence Into Practice: Case-Based Strategies for Long-Acting Anti-VEGF Agents in nAMD
Yasha Modi, MD - Putting Evidence Into Practice: Case-Based Strategies for Long-Acting Anti-VEGF Agents in nAMD

Yasha Modi, MD - Putting Evidence Into Practice: Case-Based Strategies for Long-Acting Anti-VEGF Agents in nAMD

Update: 2025-10-31
Share

Description

Please visit answersincme.com/CED860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in neovascular age-related macular degeneration (nAMD) discusses practical strategies to enhance the clinical implementation of long-acting anti-VEGF therapy. Upon completion of this activity, participants should be better able to: Select the optimal long-acting anti–vascular endothelial growth factor (VEGF) therapy for individual patients with neovascular age-related macular degeneration (nAMD); Integrate practical strategies to enhance the clinical implementation of long-acting anti-VEGF therapy in patients with nAMD; and Outline patient-centered strategies to facilitate adherence to anti-VEGF therapy.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Yasha Modi, MD - Putting Evidence Into Practice: Case-Based Strategies for Long-Acting Anti-VEGF Agents in nAMD

Yasha Modi, MD - Putting Evidence Into Practice: Case-Based Strategies for Long-Acting Anti-VEGF Agents in nAMD

Answers in CME